Cancer Vaccine Develop By Moderna and Merck Jointly
Moderna's investigational vaccine is being evaluated in a mid-stage trial with Merck's breakthrough cancer immunotherapy, Keytruda, to treat patients with melanoma, the deadliest type of skin cancer. The vaccine, mRNA-4157,…